We focus on a core set of therapeutic areas — ones where we've proven our expertise and where we have even greater potential to improve how diseases and conditions are managed. These include oncology, immunology, neuroscience, eye care, aesthetics and other areas of unmet need.
We're building on our deep expertise and legacy in immunology research to explore new disease areas, create a more patient-centric discovery and development process and offer solutions for more diverse patient populations.
We leverage our deep understanding of human biology and cutting-edge research technologies to find new ways to improve the lives of people with cancer. AbbVie is committed to drive solutions across oncology and to pioneer research to transform the standard of care for patients.
Our scientists are relentless in their pursuit of raising the standards of care for neurological diseases and disorders.With more than three decades of experience in neuroscience, we are providing meaningful treatment options today and advancing innovation for the future.
Our innovative portfolio and pipeline of new discoveries seek to maintain vision and prevent blindness. We are focused on improving the standards of care across multiple disease areas from the front to the back of the eye, from glaucoma to chronic retinal diseases.
We create products and technologies that advance aesthetic medicine. Our aesthetics R&D team seeks to discover and accelerate comprehensive, evidence-based solutions focused on novel indications, improved delivery technologies and enhanced patient outcomes.
Beyond our core areas, our research is also focused on infectious diseases — like Hepatitis C, endocrinology, diseases of the gastrointestinal tract and therapeutic neurotoxins. In these areas, a diverse set of scientific expertise is united by one vision — we believe impactful new discoveries for some of these patients are achievable.
You will be leaving your country’s AbbVie site and will be redirected to another country’s website. The AbbVie’s web site to where you will be redirected is exclusively designed for residents of particularly one or various countries, as announced in such web site. As a result, the website where you will be directed may contain pharmaceutical products information or other information that is not approved in other countries, regions or even in your country or territory of reference. If you live in a country other than those to which the site is directed, please contact your local AbbVie affiliate for the correct information on the products of your country of residence.